SCHEMBL4063270

SCHEMBL4063270

O=C1OC(C(=O)O)CC1O

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.35
IDUA P35475 1/20 0.31
GUSB P08236 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12292959 0.80 SMN1; SMN2 (0.34) SMN1; SMN2
SCHEMBL17678526 0.78 IDUA (0.36) SMN1; SMN2IDUAGUSB
SCHEMBL13758784 0.78 IDUA (0.36) SMN1; SMN2IDUAGUSB
SCHEMBL9218081 0.76 SMN1; SMN2 (0.34) SMN1; SMN2
SCHEMBL13045595 0.76 GABRR1 (0.36) SMN1; SMN2
SCHEMBL9745576 0.76 SMN1; SMN2 (0.34) SMN1; SMN2
SCHEMBL188282 0.75 SMN1; SMN2 (0.32) SMN1; SMN2
SCHEMBL2806987 0.71 POLB (0.43) SMN1; SMN2
SCHEMBL2804445 0.69 CYP2C9 (0.48) SMN1; SMN2
SCHEMBL25374614 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951285-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH Seres Therapeutics, Inc. (US) 2015-12-09 EP claimed
WO-2014121301-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH Seres Health, Inc. (US) 2014-08-07 WO claimed
EP-1501938-B1 ANALYSIS OF SUBSTRATE UTILIZATION BY ANIMAL OR PLANT CELLS BIOLOG INC (US) 2009-10-21 EP claimed
US-11666612-B2 Network-based microbial compositions and methods SERES THERAPEUTICS, INC (US) 2023-06-06 US disclosed
US-20220249578-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH SERES THERAPEUTICS, INC. (US) 2022-08-11 US disclosed
US-11185562-B2 Compositions and methods for inhibition of pathogenic bacterial growth SERES THERAPEUTICS, INC. (US) 2021-11-30 US disclosed
US-20210252079-A1 NETWORK-BASED MICROBIAL COMPOSITIONS AND METHODS Seres Therapeutics, Inc, (US) 2021-08-19 US disclosed
US-10881696-B2 Network-based microbial compositions and methods SERES THERAPEUTICS, INC. (US) 2021-01-05 US disclosed
US-20180353554-A1 Network-Based Microbial Compositions and Methods SERES THERAPEUTICS, INC. 2018-12-13 US disclosed
US-10076546-B2 Network-based microbial compositions and methods SERES THERAPEUTICS, INC. (US) 2018-09-18 US disclosed
US-20160243172-A1 Compositions and Methods for Inhibition of Pathogenic Bacterial Growth SERES THERAPEUTICS, INC. 2016-08-25 US disclosed
US-20160030494-A1 Network-Based Microbial Compositions and Methods SERES THERAPEUTICS, INC. 2016-02-04 US disclosed
EP-2951285-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH Seres Therapeutics, Inc. (US) 2015-12-09 EP disclosed
WO-2014121301-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH Seres Health, Inc. (US) 2014-08-07 WO disclosed
US-20120171618-A1 ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING A PATTERN USING THE SAME FUJIFILM CORPORATION (JP) 2012-07-05 US disclosed
US-20120171618-A1 ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING A PATTERN USING THE SAME FUJIFILM CORPORATION (JP) 2012-07-05 US disclosed